$VRTX отчёт Vertex PharmaceuticalsVRTXShare Price7 Day1 Year189.194.6%-12.0%Third quarter 2021 earnings released: EPS US$3.30 (vs US$2.56 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: US$1.98b (up 29% from 3Q 2020). Net income: US$851.9m (up 28% from 3Q 2020). Profit margin: 43% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.